معرفی
Professor Desmond Yip is a Senior Staff Specialist in Medical Oncology at The Canberra Hospital and a Professor at the ANU Medical School. His primary clinical and research focus is on gastrointestinal oncology, targeted therapies, and clinical trials, with subspecialty interests in renal cell carcinoma and gastrointestinal stromal tumors. He actively contributes to global oncology initiatives, including developing cancer services in the Solomon Islands and Papua New Guinea. He holds leadership roles in organizations such as the Medical Oncology Group of Australia and the Clinical Oncology Society of Australia's Global Oncology Group.
Education: MB BS (University of Sydney), FRACP (Royal Australasian College of Physicians). His research spans 160+ publications, including Cochrane reviews on pancreatic cancer and guidelines for colorectal cancer. Collaborations include the Australasian Gastrointestinal Trials Group and international trials in gastrointestinal stromal tumors.
Key professional roles include membership in the Cancer Institute NSW eviQ Medical Oncology Reference Committee, the American Society of Clinical Oncology Asia Pacific Regional Council, and the Australian Government Professional Services Review Panel.
His work emphasizes translational research, global health equity, and advancing therapeutic strategies in gastrointestinal malignancies and drug development. Projects include clinical trials on immunotherapy resistance and molecular determinants of immune-related adverse events.
Grants and collaborations involve initiatives like the John James Foundation and DFAT/RACP Pacific Islands Program, focusing on building oncology capacity in Pacific nations. His research also addresses venous thromboembolism risk prediction in cancer patients and psychosocial interventions for metastatic breast cancer patients.
